These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34579679)

  • 21. Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso.
    Ouédraogo A; Tiono AB; Diarra A; Sanon S; Yaro JB; Ouedraogo E; Bougouma EC; Soulama I; Gansané A; Ouedraogo A; Konate AT; Nebie I; Watson NL; Sanza M; Dube TJ; Sirima SB
    PLoS One; 2013; 8(1):e50036. PubMed ID: 23320064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria.
    de Cola MA; Sawadogo B; Richardson S; Ibinaiye T; Traoré A; Compaoré CS; Oguoma C; Oresanya O; Tougri G; Rassi C; Roca-Feltrer A; Walker P; Okell LC
    BMJ Glob Health; 2022 May; 7(5):. PubMed ID: 35589153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seasonal patterns of Plasmodium falciparum gametocyte prevalence and density in a rural population of Burkina Faso.
    Ouédraogo AL; de Vlas SJ; Nébié I; Ilboudo-Sanogo E; Bousema JT; Ouattara AS; Verhave JP; Cuzin-Ouattara N; Sauerwein RW
    Acta Trop; 2008 Jan; 105(1):28-34. PubMed ID: 17964522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
    Konaté AT; Yaro JB; Ouédraogo AZ; Diarra A; Gansané A; Soulama I; Kangoyé DT; Kaboré Y; Ouédraogo E; Ouédraogo A; Tiono AB; Ouédraogo IN; Chandramohan D; Cousens S; Milligan PJ; Sirima SB; Greenwood B; Diallo DA
    PLoS Med; 2011 Feb; 8(2):e1000408. PubMed ID: 21304925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01
    Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Tapily A; Issiaka D; Sanogo K; Mahamar A; Sompougdou F; Yerbanga S; Thera I; Milligan P; Tinto H; Ofori-Anyinam O; Ouedraogo JB; Greenwood B
    BMJ Open; 2020 Sep; 10(9):e035433. PubMed ID: 32933955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
    COSMIC Consortium
    Clin Infect Dis; 2019 Feb; 68(4):586-596. PubMed ID: 29961848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating selected host and parasite factors potentially impacting upon seasonal malaria chemoprevention in Bama, Burkina Faso.
    Somé FA; Bazié T; Ehrlich HY; Goodwin J; Lehane A; Neya C; Zachari K; Wade M; Ouattara JM; Foy BD; Dabiré RK; Parikh S; Ouédraogo JB
    Malar J; 2020 Jul; 19(1):238. PubMed ID: 32631416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of seasonal malaria chemoprevention with enhanced infection prevention and control measures during the COVID-19 pandemic in Nigeria, Burkina Faso and Chad: a cross-sectional study.
    Ward C; Phillips A; Oresanya O; Olisenekwu G; Arogunade E; Moukénet A; Beakgoubé H; De Paul Allambademel V; Compaoré CS; Traoré A; Ouedraogo JB; Compaoré YD; Zongo I; Donovan L; Decola MA; Smith H; Baker K
    Malar J; 2022 Mar; 21(1):103. PubMed ID: 35331248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the determinants of anaemia in pregnant women in rural Malawi--a basis for action.
    Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Broadhead RL
    Ann Trop Med Parasitol; 1999 Mar; 93(2):119-33. PubMed ID: 10474637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malaria and curable sexually transmitted infections in pregnant women: A two-years observational study in rural Burkina Faso.
    Zango SH; Lingani M; Valea I; Samadoulougou OS; Bihoun B; Rouamba T; Derra K; Rouamba E; Donnen P; Dramaix M; Tinto H; Robert A
    PLoS One; 2020; 15(11):e0242368. PubMed ID: 33196665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing an infection model to explain excess risk of preterm birth with long-term iron supplementation in a malaria endemic area.
    Brabin B; Tinto H; Roberts SA
    Malar J; 2019 Nov; 18(1):374. PubMed ID: 31771607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study.
    Natama HM; Rovira-Vallbona E; Somé MA; Zango SH; Sorgho H; Guetens P; Coulibaly-Traoré M; Valea I; Mens PF; Schallig HDFH; Kestens L; Tinto H; Rosanas-Urgell A
    Malar J; 2018 Apr; 17(1):163. PubMed ID: 29650007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact Evaluation of Seasonal Malaria Chemoprevention under Routine Program Implementation: A Quasi-Experimental Study in Burkina Faso.
    Druetz T; Corneau-Tremblay N; Millogo T; Kouanda S; Ly A; Bicaba A; Haddad S
    Am J Trop Med Hyg; 2018 Feb; 98(2):524-533. PubMed ID: 29260654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial.
    Bisoffi Z; Sirima BS; Angheben A; Lodesani C; Gobbi F; Tinto H; Van den Ende J
    Trop Med Int Health; 2009 May; 14(5):491-8. PubMed ID: 19222821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.
    Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Barry A; Tapily A; Nikiema F; Yerbanga S; Coumare S; Thera I; Traore A; Milligan P; Tinto H; Doumbo O; Ouedraogo JB; Greenwood B
    N Engl J Med; 2019 Jun; 380(23):2197-2206. PubMed ID: 30699301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment.
    Radeva-Petrova D; Kayentao K; ter Kuile FO; Sinclair D; Garner P
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD000169. PubMed ID: 25300703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso.
    Traore A; Donovan L; Sawadogo B; Ward C; Smith H; Rassi C; Counihan H; Johansson J; Richardson S; Savadogo JR; Baker K
    BMC Public Health; 2022 Mar; 22(1):442. PubMed ID: 35247990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study.
    Slater HC; Foy BD; Kobylinski K; Chaccour C; Watson OJ; Hellewell J; Aljayyoussi G; Bousema T; Burrows J; D'Alessandro U; Alout H; Ter Kuile FO; Walker PGT; Ghani AC; Smit MR
    Lancet Infect Dis; 2020 Apr; 20(4):498-508. PubMed ID: 31948767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malaria burden among pregnant women living in the rural district of Boromo, Burkina Faso.
    Coulibaly SO; Gies S; D'Alessandro U
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):56-60. PubMed ID: 18165475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malaria incidence during early childhood in rural Burkina Faso: Analysis of a birth cohort protected with insecticide-treated mosquito nets.
    Wehner S; Stieglbauer G; Traoré C; Sie A; Becher H; Müller O
    Acta Trop; 2017 Nov; 175():78-83. PubMed ID: 28336268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.